Literature DB >> 26655122

Genome-wide linkage on chromosome 10q26 for a dimensional scale of major depression.

Emma E M Knowles1, Jack W Kent2, D Reese McKay3, Emma Sprooten3, Samuel R Mathias3, Joanne E Curran4, Melanie A Carless2, Marcio A A de Almeida4, H H Goring Harald4, Tom D Dyer4, Rene L Olvera5, Peter T Fox6, Ravi Duggirala4, Laura Almasy4, John Blangero4, David C Glahn3.   

Abstract

Major depressive disorder (MDD) is a common and potentially life-threatening mood disorder. Identifying genetic markers for depression might provide reliable indicators of depression risk, which would, in turn, substantially improve detection, enabling earlier and more effective treatment. The aim of this study was to identify rare variants for depression, modeled as a continuous trait, using linkage and post-hoc association analysis. The sample comprised 1221 Mexican-American individuals from extended pedigrees. A single dimensional scale of MDD was derived using confirmatory factor analysis applied to all items from the Past Major Depressive Episode section of the Mini-International Neuropsychiatric Interview. Scores on this scale of depression were subjected to linkage analysis followed by QTL region-specific association analysis. Linkage analysis revealed a single genome-wide significant QTL (LOD=3.43) on 10q26.13, QTL-specific association analysis conducted in the entire sample revealed a suggestive variant within an intron of the gene LHPP (rs11245316, p=7.8×10(-04); LD-adjusted Bonferroni-corrected p=8.6×10(-05)). This region of the genome has previously been implicated in the etiology of MDD; the present study extends our understanding of the involvement of this region by highlighting a putative gene of interest (LHPP).
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26655122      PMCID: PMC4715913          DOI: 10.1016/j.jad.2015.11.012

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  70 in total

1.  Type I error rates in association versus joint linkage/association tests in related individuals.

Authors:  Jack W Kent; Thomas D Dyer; Harald H H Göring; John Blangero
Journal:  Genet Epidemiol       Date:  2007-02       Impact factor: 2.135

2.  Expression of new human inorganic pyrophosphatase in thyroid diseases: its intimate association with hyperthyroidism.

Authors:  Eisuke Koike; Shuji Toda; Fumiaki Yokoi; Kenji Izuhara; Norimasa Koike; Kouichi Itoh; Kohji Miyazaki; Hajime Sugihara
Journal:  Biochem Biophys Res Commun       Date:  2006-01-18       Impact factor: 3.575

3.  Dimensional approaches in diagnostic classification: a critical appraisal.

Authors:  Marsha F Lopez; Wilson M Compton; Bridget F Grant; James P Breiling
Journal:  Int J Methods Psychiatr Res       Date:  2007       Impact factor: 4.035

4.  Pharmacogenomics.

Authors:  E B Binder; F Holsboer
Journal:  Handb Exp Pharmacol       Date:  2005

Review 5.  Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction.

Authors:  Patricia S Goldman-Rakic; Stacy A Castner; Torgny H Svensson; Larry J Siever; Graham V Williams
Journal:  Psychopharmacology (Berl)       Date:  2004-04-30       Impact factor: 4.530

6.  Measuring depression: comparison and integration of three scales in the GENDEP study.

Authors:  R Uher; A Farmer; W Maier; M Rietschel; J Hauser; A Marusic; O Mors; A Elkin; R J Williamson; C Schmael; N Henigsberg; J Perez; J Mendlewicz; J G E Janzing; A Zobel; M Skibinska; D Kozel; A S Stamp; M Bajs; A Placentino; M Barreto; P McGuffin; K J Aitchison
Journal:  Psychol Med       Date:  2007-10-09       Impact factor: 7.723

7.  The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R).

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Doreen Koretz; Kathleen R Merikangas; A John Rush; Ellen E Walters; Philip S Wang
Journal:  JAMA       Date:  2003-06-18       Impact factor: 56.272

8.  Familiality of symptom dimensions in depression.

Authors:  Ania Korszun; Valentina Moskvina; Shyama Brewster; Nick Craddock; François Ferrero; Michael Gill; Ian Richard Jones; Lisa Anne Jones; Wolfgang Maier; Ole Mors; Michael J Owen; Martin Preisig; Theodore Reich; Marcella Rietschel; Anne Farmer; Peter McGuffin
Journal:  Arch Gen Psychiatry       Date:  2004-05

9.  Evidence for HTR1A and LHPP as interacting genetic risk factors in major depression.

Authors:  C D Neff; V Abkevich; J C L Packer; Y Chen; J Potter; R Riley; C Davenport; J DeGrado Warren; S Jammulapati; A Bhathena; W S Choi; P E Kroeger; R E Metzger; A Gutin; M H Skolnick; D Shattuck; D A Katz
Journal:  Mol Psychiatry       Date:  2008-02-12       Impact factor: 15.992

10.  Novel loci for major depression identified by genome-wide association study of Sequenced Treatment Alternatives to Relieve Depression and meta-analysis of three studies.

Authors:  S I Shyn; J Shi; J B Kraft; J B Potash; J A Knowles; M M Weissman; H A Garriock; J S Yokoyama; P J McGrath; E J Peters; W A Scheftner; W Coryell; W B Lawson; D Jancic; P V Gejman; A R Sanders; P Holmans; S L Slager; D F Levinson; S P Hamilton
Journal:  Mol Psychiatry       Date:  2009-12-29       Impact factor: 15.992

View more
  7 in total

Review 1.  Genetic, epigenetic and posttranscriptional mechanisms for treatment of major depression: the 5-HT1A receptor gene as a paradigm

Authors:  Paul R. Albert; Brice Le François; Faranak Vahid-Ansari
Journal:  J Psychiatry Neurosci       Date:  2019-05-01       Impact factor: 6.186

2.  The lipidome in major depressive disorder: Shared genetic influence for ether-phosphatidylcholines, a plasma-based phenotype related to inflammation, and disease risk.

Authors:  E E M Knowles; K Huynh; P J Meikle; H H H Göring; R L Olvera; S R Mathias; R Duggirala; L Almasy; J Blangero; J E Curran; D C Glahn
Journal:  Eur Psychiatry       Date:  2017-02-21       Impact factor: 5.361

Review 3.  The histidine phosphatase LHPP: an emerging player in cancer.

Authors:  Fahong Wu; Hanwei Ma; Xiaoli Wang; Hangzhi Wei; Wei Zhang; Youcheng Zhang
Journal:  Cell Cycle       Date:  2022-03-03       Impact factor: 5.173

4.  Clinical correlates of subsyndromal depression in African American individuals with psychosis: The relationship with positive symptoms and comorbid substance dependence.

Authors:  Emma E M Knowles; Samuel R Mathias; Godfrey D Pearlson; Jennifer Barrett; Josephine Mollon; Dominique Denbow; Katrina Aberzik; Molly Zatony; David C Glahn
Journal:  Schizophr Res       Date:  2018-10-26       Impact factor: 4.939

5.  Relationship between the LHPP Gene Polymorphism and Resting-State Brain Activity in Major Depressive Disorder.

Authors:  Lingling Cui; Xiaohong Gong; Yanqing Tang; Lingtao Kong; Miao Chang; Haiyang Geng; Ke Xu; Fei Wang
Journal:  Neural Plast       Date:  2016-10-23       Impact factor: 3.599

Review 6.  Common variants on 6q16.2, 12q24.31 and 16p13.3 are associated with major depressive disorder.

Authors:  Xiaoyan Li; Zhenwu Luo; Chunjie Gu; Lynsey S Hall; Andrew M McIntosh; Yanni Zeng; David J Porteous; Caroline Hayward; Ming Li; Yong-Gang Yao; Chen Zhang; Xiong-Jian Luo
Journal:  Neuropsychopharmacology       Date:  2018-04-27       Impact factor: 7.853

7.  Low-frequency and rare variants may contribute to elucidate the genetics of major depressive disorder.

Authors:  Chenglong Yu; Mauricio Arcos-Burgos; Bernhard T Baune; Volker Arolt; Udo Dannlowski; Ma-Li Wong; Julio Licinio
Journal:  Transl Psychiatry       Date:  2018-03-27       Impact factor: 6.222

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.